【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 Endoscopy Devices 11
3.1.1 Capsule Endoscope Systems 11
4 Company Snapshot 12
4.1 Key Facts 12
4.2 Company Overview 12
4.3 Financial Performance 12
4.4 SWOT Snapshot 12
4.5 Business Overview 13
4.6 Major Products and Services 14
4.6.1 Overview 14
5 History 15
6 SWOT Analysis 17
6.1 Overview 17
6.2 Given Imaging Ltd. Strengths 18
6.2.1 Focused R&D Activities 18
6.2.2 Broad Product Range 18
6.2.3 Diversified Geographical Presence 18
6.3 Given Imaging Ltd. Weaknesses 19
6.3.1 Dependence on Single Source Suppliers 19
6.4 Given Imaging Ltd. Opportunities 19
6.4.1 Global Endoscopy Devices Market 19
6.4.2 Product Launches and Approvals 19
6.4.3 Growing Aged Population 20
6.4.4 Inorganic Growth Drivers: Acquisitions 20
6.5 Given Imaging Ltd. Threats 21
6.5.1 Rapid Technological Change 21
6.5.2 Healthcare Reform Bill 21
6.5.3 Changing Diagnostic Market Conditions 21
6.5.4 Competitive Landscape 21
7 Competitors 22
8 Competitive Landscape 23
8.1 Endoscopy Devices (Capsule Endoscope Systems), Global, Market Share (%), 2012 23
8.2 Given Imaging Ltd., Endoscopy Devices (Capsule Endoscope Systems), by Region, Market Share (2012) 24
8.3 Given Imaging Ltd., Endoscopy Devices (Capsule Endoscope Systems), by Country, Market Share (2012) 25
9 Key Employees 27
10 Key Employee Biographies 28
11 Company Statement 30
12 Locations And Subsidiaries 32
12.1 Head Office 32
12.2 Other Locations & Subsidiaries 32
13 Financial Deals Landscape 33
13.1 Given Imaging Ltd., Deals Volume Summary, 2007 to 2013 33
14 Given Imaging Ltd. Detailed Deal Summary 35
14.1 Asset Purchase 35
14.1.1 Given Imaging Acquires SmartPill GI Monitoring Assets From SmartPill For $6 Million 35
14.1.2 Given Imaging Acquires Bravo Monitoring Business From Medtronic 37
14.2 Partnerships 39
14.2.1 Given Imaging Expands Its Distribution Agreement with FUJIFILM 39
14.2.2 Given Imaging And Fujinon Corporation Sign Global Strategic Collaboration 40
14.3 Equity Offering 41
14.3.1 Given Imaging Completes Private Placement Of $5.2 Million 41
14.4 Acquisition 42
14.4.1 Given Imaging Completes Acquisition Of Sierra Scientific Instruments From Water Street Healthcare Partners 42
14.4.2 Alpine Biomed Acquires Sierra Scientific Instruments 44
14.4.3 Elron Electronic Acquires Minority Stake In Given Imaging 45
15 Recent Developments 47
15.1 Financial Announcements 47
15.1.1 Feb 12, 2013: Given Imaging Reports Revenue Of $180.5m In 2012 47
15.1.2 Nov 06, 2012: Given Imaging Reports Revenue Of $45.4m In Q3 2012 49
15.1.3 Aug 07, 2012: Given Imaging Reports Revenue Of $44.5m In Q2 2012 50
15.1.4 May 08, 2012: Given Imaging Reports Revenue Of $41.8m In Q1 2012 51
15.1.5 Feb 14, 2012: Given Imaging Reports Revenue Of $178m In 2011 52
15.1.6 Nov 01, 2011: Given Imaging Reports Revenues Of $44.7m In Q3 2011 54
15.1.7 Aug 03, 2011: Given Imaging Reports Revenues Of $44.8m In Q2 2011 55
15.1.8 May 04, 2011: Given Imaging Reports Revenues Of $40m In Q1 2011 56
15.1.9 Feb 15, 2011: Given Imaging Reports Revenues Of $157.8m In 2010 57
15.1.10 Nov 03, 2010: Given Imaging Reports Revenues Of $38.65 Million In Q3 2010 58
15.1.11 Aug 11, 2010: Given Imaging Reports Net Profit Of $2.21 Million In Q2 2010 59
15.1.12 May 11, 2010: Given Imaging Reports Revenues Of $32.1 Million In Q1 2010 60
15.1.13 Feb 16, 2010: Given Imaging Reports Revenues Of $141.8 Million For 2009 61
15.1.14 Nov 04, 2009: Given Imaging Reports Net Profit Of $3.7 Million In Q3 2009 62
15.1.15 Aug 05, 2009: Given Imaging Reports Net Profit Of $4.6 Million In Q2 2009 63
15.1.16 May 06, 2009: Given Imaging Revenues Increases By 12% In Q1 2009 65
15.1.17 Feb 10, 2009: Given Imaging Declares Special Cash Dividend 66
15.1.18 Feb 10, 2009: Given Imaging Reports 2008 Results 66
15.1.19 Jan 19, 2009: Given Imaging To Declare 2008 Results 67
15.1.20 Nov 11, 2008: Given Imaging Reports 3Q 2008 Results 68
15.1.21 Aug 06, 2008: Given Imaging Reports 2Q 2008 Results 69
15.1.22 May 13, 2008: Given Imaging Declares Q1 2008 Results 70
15.1.23 Apr 22, 2008: Given Imaging To Declare Q1 2008 Results 71
15.1.24 Feb 20, 2008: Given Imaging Declares Q4 2007 Results 71
15.1.25 Oct 30, 2007: Given Imaging Reports Q3 2007 Results 72
15.1.26 Aug 01, 2007: Given Imaging Reports Q2 2007 Results 72
15.1.27 May 07, 2007: Given Imaging Declares Q1 2007 Results 73
15.2 Research And Development 73
15.2.1 Oct 25, 2010: Given Imaging Announces New Data Showing PillCam SB To Be Accurate Tool To Evaluate Patients With Crohn’s Disease, Functional GI Disorders And OGIB 73
15.3 Corporate Communications 75
15.3.1 Sep 25, 2008: Given Imaging CFO To Present At The JMP Securities And Maxim Group Growth Confrences 75
15.3.2 Sep 03, 2008: Given Imaging’s CEO To Present At The Morgan Stanley Conference 75
15.4 Legal and Regulatory 75
15.4.1 Jul 09, 2012: Korea Intellectual Property Tribunal Holds Given Imaging Patents Valid 75
15.4.2 Nov 30, 2011: Given Imaging Files Patent Infringement Lawsuit In Korea Against Intromedic 76
15.4.3 Mar 21, 2011: Given Imaging Wins Patent Infringement Lawsuit Against IntroMedic In Germany 76
15.4.4 Jun 17, 2008: Given Imaging Completes Patent Litigation Settlement With Olympus 77
15.5 Product News 77
15.5.1 Jan 03, 2013: Given Imaging Launches ManoView ESO v3.0 Software 77
15.5.2 Nov 27, 2012: Given Imaging Submits PillCam Colon 2 Application To FDA For US Regulatory Clearance 77
15.5.3 Oct 22, 2012: Given Imaging Announces New Studies Highlighting Diverse Applications Of ManoScan At ACG 2012 Annual Meeting 78
15.5.4 Oct 22, 2012: Given Imaging Reports New Studies On PillCam Colon 2 Presented At UEG Week In Amsterdam 79
15.5.5 Oct 21, 2012: Given Imaging Announces Data At UEG Week Confirms PillCam SB’s Role As Diagnostic Gold-Standard For Small Bowel Diseases 80
15.5.6 Sep 19, 2012: Given Imaging Submits PillCam Colon 2 Pivotal Trial Data To Japan’s PMDA For Approval 81
15.5.7 Aug 07, 2012: Given Imaging Expects To Receive FDA And PMDA Approvals For PillCam COLON 2 82
15.5.8 Jul 11, 2012: Given Imaging Announces Reimbursement In Japan For Expanded PillCam SB Indications 82
15.5.9 May 22, 2012: Given Imaging Announces Significant New Data On PillCam SB At DDW 83
15.5.10 May 22, 2012: New Studies Confirm Given Imaging’s PillCam COLON 2’s Feasibility In An Outpatient Setting 84
15.5.11 May 22, 2012: New Studies Confirm Value Of Given Imaging’s PillCam SB In Managing Pediatric Patients With Inflammatory Bowel Disease 85
15.5.12 May 20, 2012: Data Show That Capsule Endoscopy Correlates With Gastroscopy Findings: Given Imaging 85
15.5.13 May 20, 2012: Study Shows That Bravo pH Monitoring Can Be Successfully Extended In Most Cases: Given Imaging 87
15.5.14 Mar 27, 2012: Given Imaging Receives Clearance For Expanded PillCam SB Indications In Japan 88
15.5.15 Mar 12, 2012: Given Imaging Announces Publication Of Colon Capsule Endoscopy Guidelines In Endoscopy 89
15.5.16 Jan 04, 2012: Given Imaging Provides Update On PillCam COLON 2 Pivotal Trial Enrollment 90
15.5.17 Nov 15, 2011: Given Imaging Initiates Pivotal Trial For PillCam COLON 2 In Japan 90
15.5.18 Nov 02, 2011: Given Imaging Announces New Studies Highlighting Value Of ManoScan AR In Patients With Incontinence 91
15.5.19 Nov 02, 2011: New Studies Confirm Use Of Bravo Wireless pH Monitoring For Assessment Of GERD: Given Imaging 92
15.5.20 Oct 31, 2011: Given Imaging Announces New Studies Validate Use Of PillCam SB To Detect And Monitor Crohn’s Disease 93
15.5.21 Oct 25, 2011: Given Imaging Announces New Studies Highlighting Value Of ManoScan High Resolution Manometry Testing For Conditions Resulting From Anti-Reflux Surgery 94
15.5.22 Oct 25, 2011: Given Imaging Announces New Studies Showing PillCam SB Can Detect And Monitor Small Bowel Crohn’s Disease 95
15.5.23 Oct 25, 2011: Given Imaging Announces Results From Multiple PillCam COLON Studies Presented At UEGW 2011 96
15.5.24 Oct 18, 2011: Given Imaging Announces New Study Shows Impact Of PillCam SB On Management Of Symptomatic IBD Cases 96
15.5.25 Sep 26, 2011: Given Imaging Announces Positive Data Published In Gastrointestinal Endoscopy Featuring Second-Generation PillCam COLON 97
15.5.26 Jun 06, 2011: Given Imaging Initiates Trial For PillCam COLON 2 Capsule Endoscopy 98
15.5.27 May 23, 2011: Given Imaging Receives FDA Clearance For PillCam ESO 3 99
15.5.28 May 11, 2011: Given Imaging Announces Positive Results From European Multicenter Study Of PillCam COLON 2 99
15.5.29 May 10, 2011: Given Imaging Announces New Clinical Studies Recommend Increased Use Of ManoScan High Resolution Manometry To Diagnose Motility Disorders 101
15.5.30 May 10, 2011: Given Imaging Announces New Presentations Emphasize Value Of PillCam Capsule Endoscopy In Patients With Gastrointestinal Bleeding At Digestive Disease Week 2011 102
15.5.31 May 09, 2011: Given Imaging Announces New Data On Benefits Of Using Bravo Wireless pH Monitoring To Manage GERD 103
15.5.32 May 09, 2011: Given Imaging Announces New Studies Confirm PillCam SB’s Role In Management Of Patients With Suspected And Known Crohn’s Disease 104
15.5.33 Mar 10, 2011: Given Imaging Unveils Updated FDA Clearance For PillCam SB Video Capsule 105
15.5.34 Jan 05, 2011: Given Imaging Initiates Study In US For PillCam COLON 2 Capsule Endoscopy 106
15.5.35 Dec 21, 2010: Given Imaging Receives Reimbursement Code From Brazilian Medical Association For PillCam SB Capsule Endoscopy 106
15.5.36 Apr 29, 2010: Given Imaging Introduces RAPID pH Software And PillCam Express 107
15.5.37 Apr 19, 2010: Given Imaging To Complete RD-300 Trial For PillCam Express Capsule Endoscopy Delivery System In Second Quarter Of 2010 108
15.5.38 Apr 13, 2010: Given Imaging To Complete Phase III Trial For PillCam COLON 2 In First Half Of 2010 108
15.5.39 Apr 12, 2010: Given Imaging To Complete Phase I Trial For PillCam SB2 Capsule In First Quarter Of 2011 108
15.6 Product Approvals 109
15.6.1 Aug 07, 2012: Given Imaging Expects To Receive FDA And PMDA Approvals For PillCam COLON 2 109
15.6.2 Mar 27, 2012: Given Imaging Receives Clearance For Expanded PillCam SB Indications In Japan 109
15.6.3 May 23, 2011: Given Imaging Receives FDA Clearance For PillCam ESO 3 110
15.6.4 Mar 10, 2011: Given Imaging Unveils Updated FDA Clearance For PillCam SB Video Capsule 111
15.6.5 Oct 01, 2009: Given Imaging Receives FDA Nod For PillCam SB Video Capsules And Agile Patency Capsules For Use In Young Children 111
15.6.6 Oct 01, 2009: Given Imaging Receives FDA Nod For PillCam SB Video Capsules And Agile Patency Capsules For Use In Young Children 112
15.6.7 Feb 20, 2008: Given Imaging Announces PillCam COLON Approval In Israel 112
15.7 Clinical Trials 112
15.7.1 Oct 22, 2012: Given Imaging Reports New Studies On PillCam Colon 2 Presented At UEG Week In Amsterdam 112
15.7.2 May 22, 2012: New Studies Confirm Given Imaging’s PillCam COLON 2’s Feasibility In An Outpatient Setting 113
15.7.3 May 22, 2012: Given Imaging Announces Significant New Data On PillCam SB At DDW 114
15.7.4 May 22, 2012: New Studies Confirm Value Of Given Imaging’s PillCam SB In Managing Pediatric Patients With Inflammatory Bowel Disease 115
15.7.5 May 20, 2012: Study Shows That Bravo pH Monitoring Can Be Successfully Extended In Most Cases: Given Imaging 116
15.7.6 May 20, 2012: Data Show That Capsule Endoscopy Correlates With Gastroscopy Findings: Given Imaging 117
15.7.7 Jan 04, 2012: Given Imaging Provides Update On PillCam COLON 2 Pivotal Trial Enrollment 118
15.7.8 Nov 15, 2011: Given Imaging Initiates Pivotal Trial For PillCam COLON 2 In Japan 119
15.7.9 Nov 02, 2011: Given Imaging Announces New Studies Highlighting Value Of ManoScan AR In Patients With Incontinence 120
15.7.10 Nov 02, 2011: New Studies Confirm Use Of Bravo Wireless pH Monitoring For Assessment Of GERD: Given Imaging 120
15.7.11 Oct 31, 2011: Given Imaging Announces New Studies Validate Use Of PillCam SB To Detect And Monitor Crohn’s Disease 121
15.7.12 Oct 25, 2011: Given Imaging Announces New Studies Highlighting Value Of ManoScan High Resolution Manometry Testing For Conditions Resulting From Anti-Reflux Surgery 122
15.7.13 Oct 25, 2011: Given Imaging Announces New Studies Showing PillCam SB Can Detect And Monitor Small Bowel Crohn’s Disease 123
15.7.14 Oct 25, 2011: Given Imaging Announces Results From Multiple PillCam COLON Studies Presented At UEGW 2011 124
15.7.15 Oct 18, 2011: Given Imaging Announces New Study Shows Impact Of PillCam SB On Management Of Symptomatic IBD Cases 124
15.7.16 Jun 06, 2011: Given Imaging Initiates Trial For PillCam COLON 2 Capsule Endoscopy 125
15.7.17 May 11, 2011: Given Imaging Announces Positive Results From European Multicenter Study Of PillCam COLON 2 126
15.7.18 May 10, 2011: Given Imaging Announces New Clinical Studies Recommend Increased Use Of ManoScan High Resolution Manometry To Diagnose Motility Disorders 127
15.7.19 May 10, 2011: Given Imaging Announces New Presentations Emphasize Value Of PillCam Capsule Endoscopy In Patients With Gastrointestinal Bleeding At Digestive Disease Week 2011 128
15.7.20 May 09, 2011: Given Imaging Announces New Studies Confirm PillCam SB’s Role In Management Of Patients With Suspected And Known Crohn’s Disease 130
15.7.21 May 09, 2011: Given Imaging Announces New Data On Benefits Of Using Bravo Wireless pH Monitoring To Manage GERD 131
15.7.22 Jan 05, 2011: Given Imaging Initiates Study In US For PillCam COLON 2 Capsule Endoscopy 132
15.7.23 Apr 19, 2010: Given Imaging To Complete RD-300 Trial For PillCam Express Capsule Endoscopy Delivery System In Second Quarter Of 2010 132
15.7.24 Apr 13, 2010: Given Imaging To Complete Phase III Trial For PillCam COLON 2 In First Half Of 2010 132
15.7.25 Apr 12, 2010: Given Imaging To Complete Phase I Trial For PillCam SB2 Capsule In First Quarter Of 2011 133
15.8 Other Significant Developments 133
15.8.1 May 18, 2012: Given Imaging To Present New Studies At Digestive Disease Week 2012 133
15.8.2 May 03, 2011: Given Imaging To Present Product Lines At Digestive Disease Week 2011 133
15.8.3 Jan 20, 2009: Given Imaging Announces Expansion Of Distribution Agreement With FUJIFILM 134
15.8.4 Sep 25, 2008: Given Imaging CFO To Present At The JMP Securities And Maxim Group Growth Confrences 134
15.8.5 Sep 03, 2008: Given Imaging’s CEO To Present At The Morgan Stanley Conference 135
15.8.6 Feb 26, 2008: Given Imaging Wins FSS Contract With VA 135
16 Appendix 136
16.1 Research Methodology 137
16.2 Secondary Research 137
16.3 Primary Research 137
16.4 Models 138
16.5 Forecasts 138
16.6 Expert Panels 138
16.7 GlobalData Consulting 138
16.8 Currency Conversion 139
16.9 Contact Us 140
16.10 Disclaimer 140
【レポート販売概要】
■ タイトル：Given Imaging Ltd.：市場シェア分析■ 英文：Given Imaging Ltd. Market Share Analysis
■ 発行日：2013年3月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160638
■ 調査対象地域：グローバル
- 組み込みプロセッサの世界市場：タイプ別（マイクロプロセッサ、マイクロコントローラ、デジタル信号プロセッサ、eFPGAなど）、用途別（コンシューマーエレクトロニクス、自動車、産業、ヘルスケア、IT＆テレコム、航空宇宙および防衛、その他）An embedded processor is especially designed for handling the needs of an embedded system and to handle multiple processor in real time. A processor embedded into a system handles all the computational and logical operation of a computer. These processors are in the form of a computer chip that is embedded in various microcontrollers and microprocessors to control various electrical and mechanical …
- 港湾設備の世界市場予測（～2025年）Increasing seaborne trade across the globe and growing number of container shipments in Asia Pacific and the Middle East are the major factors for the growth of the global port equipment market. The port equipment market size is expected to grow from USD 29.2 billion in 2018 to USD 36.6 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 3.30% during the forecast period. The market for por …
- 産業用ターボチャージャーの世界市場2016-2020About the Industrial Turbocharger Market Efficiency and power of an engine or motor dictate the overall functioning of the machine. The engine output is determined by the amount of air and fuel entering the internal combustion engine under high pressure. A turbocharger is an example of a forced induction system as it supplies high pressurized exhaust gas to the engine, making more air available fo …
- 水性UV硬化樹脂の世界市場予測（～2020）The waterborne UV curable resins market, in terms of value, is projected to reach USD 230.3 Million by 2020, growing at a CAGR of over 13.52% from 2015 to 2020. The key drivers of the waterborne UV curable resins market are environmental concerns, growing awareness, and increasingly stringent regulations for VOC emissions. Dispersions of urethane acrylates (UV-PUDs), often combined with physical d …
- グローバル半導体市場におけるトップ10企業分析Synopsis The Kable Global Top 10 Semiconductor Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global semiconductor industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated. Intel Corporation Flextronics International Ltd. Ta …
- 顔料分散の世界市場展望2017-2026According to Stratistics MRC, the Global Pigment Dispersions is accounted for $37.21 billion in 2017 and is expected to reach $65.58 billion by 2026 growing at a CAGR of 6.5% during the forecast period. Rising demand for paints and coatings, booming construction industry and increasing applications of pigment dispersions in emerging economies are the key driving factors for the market growth. Howe …
- Delphi Energy Corp.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Delphi Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Delphi Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 西ヨーロッパ（WE）のコネクティッド・カーM2M通信およびサービス市場About Connected Car M2M Connections and Services Connected cars enable drivers to connect with online platforms and obtain real-time communication such as real-time traffic updates during travel. Different factors such as rising demand for constant connectivity, increased dependence on technology, and the growing number of tech-savvy customers have fueled the growth of the connected car M2M connec …
- オーストラリアのビチューメン及びアスファルト市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Australia and its perspectives on the global market for Bitumen and asphalt, natural. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Bitumen and asphalt, natural export/import operations in Australia. The 2002 …
- 世界における後天的遺伝子変異または後天的染色体変異検査製品のパイプライン動向2015Acquired Gene or Chromosome Alterations - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Acquired Gene or Chromosome Alterations - Pipeline Review, 2015" provides an overview of genetic tests for Acquired Gene or Chromosome Alterations currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the pro …
- アンモニアの世界市場動向Global Ammonia Outlook - Production Capacity set to Continue Strong Growth Led by United States and Iran Summary Global ammonia capacity is seeing changes as in various parts of the world due to their feedstock advantages. With large capacity additions in North America and Middle East & Africa, the regions are leveraging on cost favourable and large-scale available feedstock. In North America, amm …
- ブレーキ摩擦製品の世界市場：ブレーキパッド、ブレーキシュー、ブレーキライナー、ブレーキディスク、ブレーキドラムThe brake friction products original equipment (OE) market is projected to grow from USD 26.91 Billion in 2016 to USD 38.96 Billion by 2021, at a CAGR of 7.68%. The increasing vehicle production, sales, and parc is one of the key factors driving the brake friction products market. Brake pads are estimated to constitute the fastest growing aftermarket segment, in terms of volume. The average replac …
- 足関節全置換：グローバル市場分析と予測MediPoint: Total Ankle Replacement - Global Analysis and Market Forecasts Summary Ankle arthritis is a severe and debilitating problem with notable increasing prevalence in both the developed and developing world. In a society constantly seeking out a modern lifestyle, sports-related injuries, trauma, aging, and obesity are contributing to an increased incidence of ankle arthritis. Total ankle rep …
- コイル塗装の世界市場2016-2020About Coil Coatings Coil coatings, also called prepainted metal coatings, are used to coat metal surfaces before they are made into end products. They are eco-friendly, cause minimal volatile organic carbon (VOC) emissions, do not consume a lot of energy, and result in limited waste. They have many advantages over post-painted metal coatings, such as corrosion protection and long-term aesthetic va …
- Gasco Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Gasco Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Gasco Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
